These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1532631

  • 21. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
    Leslie WD, Abrams DN, Greenberg CR, Hobson D.
    J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. D2 receptor imaging with iodine-123-iodobenzamide brain SPECT in infants with hypoxic-ischemic brain injury.
    Kapucu LO, Koç E, Gücüyener K, Zenciroğlu A, Atalay Y, Unlü M, van Royen E.
    J Nucl Med; 1998 Oct; 39(10):1703-7. PubMed ID: 9776272
    [Abstract] [Full Text] [Related]

  • 24. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T.
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [Abstract] [Full Text] [Related]

  • 25. Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
    Schwarz J, Antonini A, Tatsch K, Kirsch CM, Oertel WH, Leenders KL.
    Nucl Med Commun; 1994 Oct; 15(10):806-13. PubMed ID: 7838444
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS, Costa DC, Ell PJ, Verhoeff NP, Murray RM, Kerwin RW.
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K.
    Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
    Arnold G, Tatsch K, Kraft E, Oertel WH, Schwarz J.
    Mov Disord; 2002 May; 17(3):557-62. PubMed ID: 12112207
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, de Bruin K, van Royen EA.
    Int J Rad Appl Instrum B; 1991 May; 18(8):837-46. PubMed ID: 1839302
    [Abstract] [Full Text] [Related]

  • 37. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.
    Schröder J, Bubeck B, Silvestri S, Demisch S, Sauer H.
    Psychiatry Res; 1997 Sep 29; 75(2):115-23. PubMed ID: 9351493
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.